Summary
Hospitals are advocating for new pricing regulations for medical devices, citing significant costs beyond procurement and high markups flagged by the Maharashtra FDA. They suggest a differentiated framework, distinguishing between routine consumables and complex technologies, as the center requests a report from the National Pharmaceutical Pricing Authority.